[PubMed ID: 25216328]
Melatonin supplementation (3 mg/day) has been shown to improve objective and subjective sleep quality, increase 6-sulfatoxymelatonin levels, and enhance total antioxidant capacity in FM patients, suggesting dual chronobiotic and antioxidant benefits (31)
The neuroprotective effects of a novel oral treatment, BG12 (dimethyl fumarate) has been recently shown to slow disease progression in relapsing/remitting MS in phase III trials
I am very fair skinned (celticscottish equals blue rather than fair skin) and freckly, I always burn and never tan
GLP-1 Drug Repurposing for Addiction Disorders Hampered by High Costs and Legal Hurdles Don Tracy, Associate Editor Armando Castro, partner, emerging companies, venture capital, Lowenstein Sandler, explains how regulatory, patent, and reimbursement challenges are slowing venture investment in GLP-1 and psychedelic addiction therapies
The Evolution of Medical Weight Loss in New Jersey: Semaglutide vs